As part of Premier’s Technology Breakthroughs Program, Osprey Medical, Inc. has been awarded a group purchasing agreement giving Premier’s ~4,000 U.S. hospitals access to purchase the DyeVert Plus Contrast Reduction System. Osprey Medical’s DyeVert Plus System is the only technology cleared by the U. S. Food & Drug Administration for contrast reduction and real-time monitoring of dye dose delivered to patients during a coronary or peripheral angiogram. Use of the DyeVert Plus System has resulted in a mean 40% contrast media (dye) volume reduction, which has been shown to be statistically significant and clinically meaningful.
https://ospreymed.com/wp-content/uploads/2018/12/premier-logo.jpg 610 610 Cat Gilfillen /wp-content/uploads/2017/04/osprey-logo-224w.png Cat Gilfillen2018-12-11 20:47:232018-12-11 21:03:21Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System